Loading insider details...
Beta
Latest Form 4 (May 5, 2026): Grant/Award of 1,129,323 KTTA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 5, 2026 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 1,129,323 | n/a |
| Dec 1, 2025 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 26,667 | $20.0K |
| Oct 27, 2025 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 317,266 | n/a |
| Mar 2, 2024 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 10,000 | n/a |
| Oct 13, 2022 | Pasithea Therapeutics Corp. (KTTA) | Grant/Award | 300,000 | n/a |
| Jan 4, 2022 | First Wave BioPharma, Inc. (FWBI) | Grant/Award | 10,000 | n/a |
| Jul 2, 2021 | AzurRx BioPharma, Inc. (AZRX) | Other (see footnotes) | 35,006 | n/a |
| Jul 21, 2020 | AzurRx BioPharma, Inc. (AZRX) | Other (see footnotes) | 35,006 | n/a |
| Jan 9, 2020 | AzurRx BioPharma, Inc. (AZRX) | Grant/Award | 335,006 | n/a |